Clinical Trial

Cancer Clinical Trial 20223000

[LCID Study Number: 20223000]

Correlation of Quality of Life and Microbiome in Older Cancer Patients

The purpose of this study is to evaluate the correlation of microbiome diversity and bacterial metabolites in solid tumor older cancer patients receiving immune checkpoint inhibitors with quality of life.

Disease/Condition: COPD

Department: Hematology and Oncology

Location(s): Lahey Hospital & Medical Center (Burlington), Lahey Medical Center Peabody

Primary Contact Email:

Primary Contact Phone: 781-744-3421

Clinical Trial Details

Protocol #: 20223000

Principal Investigator(s): Krishna S Gunturu

Study Coordinator(s): Julia Roache

Trial Phase: Investigator Initiated Study Observational